Risultati della ricerca - Yaping Long

Efficacy and safety of first-line chemoimmunotherapy in young patients with extensive-stage small cell lung cancer: a multicenter retrospective study di Lijuan Zhao, Qi Xiong, Yaping Long, Haiming Hu, Zhouhuan Dong, Fengwei Zhu, Jun Zhao, Bo Yang, Jingzhi Guan

Testo

Hypoalbuminemia induces immunosuppression through disorder in macrophages and drives resistance to immune checkpoint inhibitors di Fan Yang, Yaping Long, Yao Li, Yibing Bai, Yining Liu, Dingyuan Cheng, Tao Li, Yiheng Lu, Xiao Han, Yi Hu

Testo

Radiation-Induced Tumor-Derived Extracellular Vesicles Combined with Tyrosine Kinase Inhibitors: An Effective and Safe Therapeutic Approach for Lung Adenocarcinoma with EGFR19Del di Yao Li, Yaping Long, Xiangwei Ge, Pengfei Zhang, Tao Li, Liangliang Wu, Hao Fan, Zhijuan Du, Qiaowei Liu, Yi Hu

Testo

Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study di Yaping Long, Wenyu Yang, Yibing Bai, Haitao Tao, Fan Zhang, Lijie Wang, Bo Yang, Di Huang, Xiao Han, Yi Hu

Testo

Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma di Yaping Long, Zihe Gao, Xiao Hu, Feng Xiang, Zhaozhen Wu, Jiahui Zhang, Xiao Han, Liyong Yin, Junfang Qin, Lan Lan, Fuzai Yin, Yue Wang

Testo

Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study di Boyu Qin, Lingli Xin, Chen Liang, Lingling Li, Qi Song, Yaping Long, Xiaoling Zhang, Dan Wang, Weiwei Shi, Jing Zhang, Yi Hu, Bo Yang, Qi Xiong

Testo

Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study di Pengfei Cui, Zhefeng Liu, Guoqiang Wang, Junxun Ma, Yuanyu Qian, Fan Zhang, Chun Han, Yaping Long, Ye Li, Xuan Zheng, Danyang Sun, Jing Zhang, Shangli Cai, Shunchang Jiao, Yi Hu

Testo